Depressed plasma activity of plasminogen or α2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation
- 1 June 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 12 (4), 275-281
- https://doi.org/10.1097/00001721-200106000-00008
Abstract
We have attempted to determine whether depressed plasma plasminogen and α2 plasmin inhibitor (or α2 antiplasmin) activity is, as a result of consumption coagulopathy, a specific finding of disseminated intravascular coagulation (DIC) in septic patients. The hemostatic parameters of 139 septic patients (68 with DIC and 71 without DIC) were analyzed. Among the group as a whole, plasma activities of plasminogen and α2 plasmin inhibitor were significantly depressed in septic patients with DIC relative to those without DIC (P < 0.01 and P < 0.05, respectively). Notably, a significant correlation was observed between plasma levels of albumin and plasminogen activity, as well as between plasma levels of albumin and α2 plasmin inhibitor activity both in septic patients with DIC and those without DIC. However, no significant correlation was observed between plasma levels of plasmin–α2 plasmin inhibitor complex (PIC) and plasminogen activity, nor between PIC and α2 plasmin inhibitor activity either in septic patients with DIC or those without DIC. We concluded that depressed activity of plasminogen or α2 plasmin inhibitor is not as a result of consumption coagulopathy, but rather a result of low synthetic function of the liver in septic patients with DIC.Keywords
This publication has 22 references indexed in Scilit:
- Disseminated Intravascular CoagulationNew England Journal of Medicine, 1999
- Disseminated intravascular coagulation: Clinical and laboratory aspectsAmerican Journal of Hematology, 1998
- Antithrombin: Its Physiological Importance and Role in DICSeminars in Thrombosis and Hemostasis, 1998
- Long-term Follow-up of Hemostatic Molecular Markers during Remission Induction Therapy with All-Trans Retinoic Acid for Acute Promyelocytic LeukemiaThrombosis and Haemostasis, 1997
- Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markersBlood Coagulation & Fibrinolysis, 1994
- Septic Shock, Multiple Organ Failure, and Disseminated Intravascular CoagulationChest, 1992
- Thrombin Vs. Plasmin generation in disseminated lntravascular coagulation associated with various underlying disordersAmerican Journal of Hematology, 1990
- Epsilon-Aminocaproic Acid in the Treatment of Patients with Acute Promyelocytic Leukemia and Acquired Alpha-2-Plasmin Inhibitor DeficiencyAnnals of Internal Medicine, 1986
- α2antiplasmin and disseminated intravascular coagulation in liver cirrhosisThrombosis Research, 1985
- Selective determination of α2-plasmin inhibitor activity in plasma using chromogenic substrateThrombosis Research, 1984